MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 244 filers reported holding MYRIAD GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $459,000 | +97.0% | 16,855 | +100.7% | 0.01% | +75.0% |
| Q2 2019 | $233,000 | -64.6% | 8,400 | -57.6% | 0.00% | -75.0% |
| Q1 2019 | $658,000 | +121.5% | 19,822 | +141.7% | 0.02% | +300.0% |
| Q3 2017 | $297,000 | -61.2% | 8,200 | -72.3% | 0.00% | -55.6% |
| Q2 2017 | $766,000 | +0.5% | 29,621 | -25.4% | 0.01% | 0.0% |
| Q1 2017 | $762,000 | -8.0% | 39,686 | -20.1% | 0.01% | +12.5% |
| Q4 2016 | $828,000 | – | 49,650 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |